What is blood transfusion?

Blood transfusion is the intravenous administration of whole blood or specific blood components such as packed red blood cells, platelets, plasma, or cryoprecipitate to restore oxygen-carrying capacity, correct coagulopathy, or replace blood loss.

What are the main indications for packed red blood cell transfusion?

PRBC transfusion is indicated in acute blood loss, symptomatic anemia, hemoglobin less than 7 g/dL in stable adults, hemoglobin less than 8 g/dL in patients with cardiovascular disease, and ongoing hemorrhagic shock.

What is massive blood transfusion?

Massive blood transfusion is defined as transfusion of 10 or more units of PRBCs within 24 hours, 4 or more units within 1 hour with ongoing bleeding, or replacement of more than 50 percent of blood volume within 3 hours.

When should a massive transfusion protocol be activated?

MTP should be activated in patients with life-threatening hemorrhage such as major trauma, postpartum hemorrhage, ruptured aneurysm, massive gastrointestinal bleeding, or uncontrolled surgical bleeding with hemodynamic instability.

What is the recommended transfusion ratio in massive transfusion protocol?

The recommended ratio is 1:1:1 using packed red blood cells, fresh frozen plasma, and platelets to prevent dilutional coagulopathy and improve survival.

Why is calcium supplementation required during massive transfusion?

Citrate used as an anticoagulant in stored blood binds ionized calcium, leading to hypocalcemia which can cause hypotension, arrhythmias, and reduced myocardial contractility.

What are the most common complications of blood transfusion?

Common complications include febrile non-hemolytic transfusion reactions, allergic reactions, transfusion-associated circulatory overload, transfusion-related acute lung injury, hemolytic reactions, and transfusion-transmitted infections.

How can TRALI be differentiated from TACO?

TRALI presents with acute hypoxemia, hypotension, and non-cardiogenic pulmonary edema, while TACO presents with hypertension, raised JVP, volume overload, elevated BNP, and improves with diuretics.

What laboratory parameters should be monitored during massive transfusion?

Monitoring includes hemoglobin, platelet count, INR, PT, aPTT, fibrinogen levels, arterial blood gas, lactate, ionized calcium, electrolytes, and core body temperature.

What is the role of tranexamic acid in massive transfusion?

Tranexamic acid reduces fibrinolysis and mortality when given early within 3 hours of trauma-related hemorrhage, usually as a 1 g IV bolus followed by 1 g infusion over 8 hours.

When is platelet transfusion indicated?

Platelet transfusion is indicated when platelet count is below 10,000 per microliter prophylactically, below 20,000 with fever or sepsis, below 50,000 with active bleeding or surgery, and below 100,000 for neurosurgery.

When should fresh frozen plasma be transfused?

FFP is indicated in active bleeding with INR greater than 1.5, massive transfusion, liver disease with bleeding, disseminated intravascular coagulation, and reversal of warfarin when PCC is unavailable.

What is cryoprecipitate and when is it used?

Cryoprecipitate is rich in fibrinogen, factor VIII, factor XIII, and von Willebrand factor, and is used when fibrinogen levels fall below 150 to 200 mg/dL, especially in massive hemorrhage or DIC.

What is the first step in managing a suspected acute hemolytic transfusion reaction?

The first step is to immediately stop the transfusion, maintain intravenous access with normal saline, assess the patient, and send blood and urine samples for hemolysis workup.

When should massive transfusion protocol be stopped?

MTP should be discontinued once bleeding is controlled, the patient is hemodynamically stable, transfusion requirements decrease, and coagulation parameters begin to normalize.

BLOOD TRANSFUSION AND MASSIVE BLOOD TRANSFUSION PROTOCOL

(Comprehensive Clinical Guide)

1. BLOOD TRANSFUSION

1.1 Definition

Blood transfusion is the intravenous administration of whole blood or specific blood components to restore circulating volume, improve oxygen-carrying capacity, or correct coagulation abnormalities.

1.2 Types of Blood Products

A. Whole Blood

Contains RBCs, plasma, platelets
Rarely used (trauma with massive hemorrhage in select centers)

B. Packed Red Blood Cells (PRBCs)

Raises oxygen delivery
1 unit ↑ Hb by ~1 g/dL (adult)

C. Platelet Concentrates

Random donor platelets (RDP)
Single donor platelets (SDP/apheresis)

D. Fresh Frozen Plasma (FFP)

All coagulation factors
Volume ~200–250 mL/unit

E. Cryoprecipitate

Rich in fibrinogen, Factor VIII, XIII, vWF

F. Plasma Derivatives

Albumin, immunoglobulins, factor concentrates

1.3 Indications for Blood Transfusion

A. PRBC Transfusion

| Clinical Situation | Transfusion Threshold |

| -------------------------- | --------------------- |

| Stable, non-bleeding adult | Hb <7 g/dL |

| Cardiovascular disease | Hb <8 g/dL |

| Ongoing bleeding/shock | Clinical judgment |

| Perioperative | Hb <7–8 g/dL |

B. Platelet Transfusion

| Situation | Platelet Count |

| ----------------------- | -------------- |

| Prophylaxis | <10,000/µL |

| Fever/sepsis | <20,000/µL |

| Active bleeding/surgery | <50,000/µL |

| Neurosurgery | <100,000/µL |

C. FFP

Active bleeding with INR >1.5
DIC
Liver disease with bleeding
Massive transfusion

D. Cryoprecipitate

Fibrinogen <150–200 mg/dL
DIC, massive hemorrhage
Congenital hypofibrinogenemia

1.4 Pre-Transfusion Testing

ABO grouping
Rh typing
Antibody screening
Cross-matching

* Major crossmatch (recipient serum + donor RBCs)

1.5 Transfusion Procedure (Stepwise)

Confirm indication and consent
Verify patient identity (2 identifiers)
Baseline vitals
Start transfusion slowly (first 15 min)
Monitor vitals at 15 min, hourly, post-transfusion
Complete within:

* PRBCs: ≤4 hours

* Platelets: ≤30–60 min

* FFP: ≤2 hours

1.6 Complications of Blood Transfusion

A. Acute (≤24 hours)

1. Acute Hemolytic Transfusion Reaction (AHTR)

Cause: ABO incompatibility
Features: Fever, chills, back pain, hemoglobinuria, shock
Management:

* Stop transfusion immediately

* IV fluids, maintain urine output

* Send blood and urine for hemolysis workup

2. Febrile Non-Hemolytic Reaction

Cytokines from donor leukocytes
Treat: Antipyretics

3. Allergic Reaction

Urticaria → antihistamines
Anaphylaxis (IgA deficiency) → epinephrine

4. TRALI (Transfusion-Related Acute Lung Injury)

Non-cardiogenic pulmonary edema
Treat: Oxygen, ventilatory support

5. TACO (Transfusion-Associated Circulatory Overload)

Volume overload
Treat: Diuretics, slow transfusion

B. Delayed Complications

Delayed hemolytic reaction
Iron overload (chronic transfusion)
Alloimmunization
Transfusion-transmitted infections (HBV, HCV, HIV – rare)

1.7 Special Transfusion Situations

A. Emergency Transfusion

Use O negative PRBCs
Group-specific as soon as possible

B. Transfusion in Pregnancy

Rh-negative mothers → Anti-D prophylaxis

C. Pediatric Transfusion

Dose-based (10–15 mL/kg PRBC)

2. MASSIVE BLOOD TRANSFUSION PROTOCOL (MTP)

2.1 Definition

Massive transfusion is defined as:

≥10 units PRBCs in 24 hours

≥4 units PRBCs in 1 hour with ongoing bleeding

Replacement of ≥50% blood volume in 3 hours

2.2 Indications for MTP Activation

Major trauma with hemorrhagic shock
Obstetric hemorrhage (PPH)
GI bleeding with shock
Major surgery with uncontrolled bleeding
Ruptured aneurysm

2.3 Goals of MTP

Restore oxygen delivery
Prevent coagulopathy
Avoid hypothermia, acidosis, hypocalcemia

(Lethal Triad)

2.4 MTP Blood Component Ratio

Balanced Transfusion Strategy (Damage Control Resuscitation)

| Component | Ratio |

| ------------ | ----- |

| PRBCs | 1 |

| Plasma (FFP) | 1 |

| Platelets | 1 |

➡ 1:1:1 ratio

2.5 Standard MTP Pack (Example)

Pack 1

4 PRBCs
4 FFP
1 platelet unit

Pack 2

Repeat + cryoprecipitate (if fibrinogen low)

2.6 Laboratory Monitoring During MTP

Hb/Hct
Platelet count
INR/PT/aPTT
Fibrinogen
ABG (pH, lactate)
Ionized calcium
Core temperature

(Prefer viscoelastic testing: TEG/ROTEM if available)

2.7 Adjunctive Therapies in MTP

A. Tranexamic Acid (TXA)

Indication: Trauma with hemorrhage within 3 hours
Dose:

* 1 g IV over 10 min

* Then 1 g over 8 hours

B. Calcium Replacement

Citrate toxicity → hypocalcemia
Give:

* Calcium gluconate 10 mL IV

* Or calcium chloride (central line)

C. Warming Measures

Blood warmers
Forced air warming blankets

2.8 Complications of Massive Transfusion

| Complication | Mechanism |

| ----------------------- | ------------------- |

| Dilutional coagulopathy | Factor dilution |

| Hypocalcemia | Citrate binding |

| Hypothermia | Cold blood |

| Metabolic acidosis | Shock, lactate |

| Hyperkalemia | Stored RBCs |

| ARDS | TRALI, inflammation |

2.9 Stopping Criteria for MTP

Hemodynamic stability
Controlled bleeding
Normalizing coagulation profile
Reduced transfusion requirement

3. COMPARISON: ROUTINE VS MASSIVE TRANSFUSION

| Feature | Routine | Massive |

| ---------- | ------------------ | ---------------------------- |

| Indication | Anemia/bleeding | Life-threatening hemorrhage |

| Ratio | Component-specific | 1:1:1 |

| Monitoring | Intermittent | Continuous |

| Adjuncts | Rare | TXA, calcium |

| Risk | Lower | High metabolic complications |

4. KEY EXAM & CLINICAL PEARLS

Hb threshold alone should not dictate transfusion in shock
Early plasma and platelets reduce mortality in trauma
Hypocalcemia is common and often overlooked in MTP
Always suspect TRALI vs TACO in post-transfusion respiratory distress
Transfusion is a treatment with risks, not benign fluid

5. SUMMARY

Blood transfusion should be indication-driven and component-specific
Massive transfusion requires early, balanced, protocol-based resuscitation
Continuous monitoring and complication prevention are critical
Proper protocols save lives in trauma, obstetrics, and surgery

Blood Transfusion and Massive Blood Transfusion Protocol Complete Clinical Guide